BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18221365)

  • 1. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
    Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
    Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
    Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
    Choudhury KR; Das S; Bhattacharyya NP
    J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
    Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
    Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.
    Saavedra A; Giralt A; Rué L; Xifró X; Xu J; Ortega Z; Lucas JJ; Lombroso PJ; Alberch J; Pérez-Navarro E
    J Neurosci; 2011 Jun; 31(22):8150-62. PubMed ID: 21632937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
    Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
    Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells.
    Das E; Jana NR; Bhattacharyya NP
    Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
    Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
    Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
    Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS
    Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.
    Anglada-Huguet M; Giralt A; Perez-Navarro E; Alberch J; Xifró X
    J Neurochem; 2012 May; 121(4):639-48. PubMed ID: 22372926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
    Quintanilla RA; Jin YN; Fuenzalida K; Bronfman M; Johnson GVW
    J Biol Chem; 2008 Sep; 283(37):25628-25637. PubMed ID: 18640979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
    Trettel F; Rigamonti D; Hilditch-Maguire P; Wheeler VC; Sharp AH; Persichetti F; Cattaneo E; MacDonald ME
    Hum Mol Genet; 2000 Nov; 9(19):2799-809. PubMed ID: 11092756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.
    Xifró X; Giralt A; Saavedra A; García-Martínez JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Neurobiol Dis; 2009 Dec; 36(3):461-9. PubMed ID: 19733666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 Plays an Anti-apoptotic Role in Mutant Huntingtin Expression Striatal Progenitor Cells.
    Jen WP; Chen HM; Lin YS; Chern Y; Lee YC
    Mol Neurobiol; 2020 Mar; 57(3):1688-1703. PubMed ID: 31813126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells.
    Gines S; Ivanova E; Seong IS; Saura CA; MacDonald ME
    J Biol Chem; 2003 Dec; 278(50):50514-22. PubMed ID: 14522959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.